The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).

There is a GoFundMe and T-shirt drive set up to help support the Hicks family on this journey. All proceeds will go towards ...

More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green ...

Despite research showing the benefits of circulating tumor DNA as an indicator of disease remission in B-cell lymphoma, ...

B-cells produce antibodies to attack bacteria ... There is some overlap in the definitions for some subtypes, such as T-lymphoblastic lymphoma/leukemia and adult T-cell lymphoma/leukemia.

The direct antiglobulin test was positive for anti-C3d specificity, with cold agglutinin titer confirming the diagnosis of CAD.

Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

Stripping and reprobing the membrane with an antibody that recognized STAT5A and B showed differential STAT5 protein expression for each tumor (Figure 1c). To further demonstrate the presence and ...

The Scottish Medicines Consortium has backed NHS funding for Gilead’s CAR-T therapy Yescarta for B-cell lymphomas ... cleared for use in acute lymphoblastic lymphoma (ALL).

SAN DIEGO — A bicistronic chimeric antigen receptor T-cell therapy induced durable response for most children with relapsed or refractory B-lineage acute lymphoblastic leukemia, findings ...

Pet owners can bring in their cats and dogs Saturday to Wizard of Paws for nail trims that will benefit a local girl battling ...